The Q368STOP Myocilin Mutation in a Population-based Cohort: The Blue Mountains Eye Study

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ajo.2004.11.061 Byline: Paul N. Baird (a), Andrea J. Richardson (a), Jamie E. Craig (a)(b), Elena Rochtchina (c), David A. Mackey (a)(d), Paul Mitchell (d) Abstract: To investigate the prevalence of the Q368STOP myocilin mutation in a population-based cohort: the Blue Mountains Eye Study (BMES). Author Affiliation: (a) Centre for Eye Research Australia, University of Melbourne, East Melbourne, Victoria (b) Department of Ophthalmology, Flinders Medical Centre, Adelaide, South Australia; (c) University of Sydney Department of Ophthalmology, Centre for Vision Research, Westmead Hospital, Westmead, New South Wales (d) The Menzies Centre for Population Health Research, University of Tasmania, Hobart, Tasmania, Australia. Article History: Accepted 29 November 2004 Article Note: (footnote) This authors received support from the Dorothy Edols Trust and the Australian National Health & Medical Research Council.